Synthesis from quebrachitol of 1L-chiro-inositol 2,3,5-trisphosphate, an inhibitor of the enzymes of 1D-myo-inositol 1,4,5-trisphosphate metabolism

[1]  A. P. Briggs A MODIFICATION OF THE BELL-DOISY PHOSPHATE METHOD , 1922 .

[2]  S. Hanessian,et al.  Regioselective manipulation of hydroxyl groups via organotin derivatives , 1985 .

[3]  M. Berridge,et al.  Inositol trisphosphate and diacylglycerol: two interacting second messengers. , 1987, Annual review of biochemistry.

[4]  A. Trzeciak,et al.  A Simple and Effective Chemical Phosphorylation Procedure for Biomolecules , 1987 .

[5]  S H Snyder,et al.  Solubilization, purification, and characterization of an inositol trisphosphate receptor. , 1988, The Journal of biological chemistry.

[6]  J. Huff,et al.  Metabolism of synthetic inositol trisphosphate analogs. , 1988, The Journal of biological chemistry.

[7]  Teiichi Furuichi,et al.  Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400 , 1989, Nature.

[8]  B. Potter,et al.  myo‐Inositol 1,4,5‐trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5‐phosphatase , 1989, FEBS letters.

[9]  R. Huganir,et al.  Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles , 1989, Nature.

[10]  B. Potter,et al.  Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes. , 1989, Trends in pharmacological sciences.

[11]  H. Carless,et al.  Total synthesis of chiro-inositol 2,3,5-trisphosphate: A myo-inositol 1,4,5-trisphosphate analogue from benzene via photo-oxidation , 1990 .

[12]  B. Potter,et al.  Recent advances in the chemistry and biochemistry of inositol phosphates of biological interest. , 1990, Natural product reports.

[13]  M. Hirata,et al.  Stereospecific recognition of inositol 1,4,5-trisphosphate analogs by the phosphatase, kinase, and binding proteins. , 1990, The Journal of biological chemistry.

[14]  R. Wojcikiewicz,et al.  Ca2+‐mobilising properties of synthetic fluoro‐analogues of myo‐inositol 1,4,5‐trisphosphate and their interaction with myo‐inositol 1,4,5‐trisphosphate 3‐kinase and 5‐phosphatase , 1990, FEBS letters.

[15]  T. Südhof,et al.  Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. , 1990, The Journal of biological chemistry.

[16]  C. Ballou,et al.  Synthesis and Ca(2+)-release activity of D- and L-myo-inositol 2,4,5-trisphosphate and D- and L-chiro-inositol 1,3,4-trisphosphate. , 1991, Carbohydrate research.

[17]  R. Wojcikiewicz,et al.  Interaction of synthetic D‐6‐deoxy‐myo‐inositol 1,4,5‐trisphosphate with the Ca2+‐releasing D‐myo‐inositol 1,4,5‐trisphosphate receptor, and the metabolic enzymes 5‐phosphatase and 3‐kinase , 1991, FEBS letters.

[18]  R. Wojcikiewicz,et al.  Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase. , 1991, Molecular pharmacology.

[19]  S. Penadés,et al.  The allylation of dibutylstannylene derivatives of myo-inositol , 1992 .

[20]  B. Potter,et al.  3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition. , 1992, European journal of pharmacology.